
Bridget E. Bunner
Examiner (ID: 1937, Phone: (571)272-0881 , Office: P/1647 )
| Most Active Art Unit | 1647 |
| Art Unit(s) | 1644, 1647 |
| Total Applications | 1465 |
| Issued Applications | 728 |
| Pending Applications | 154 |
| Abandoned Applications | 602 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 4718685
[patent_doc_number] => 20080241207
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-10-02
[patent_title] => 'Methods and materials relating to novel stem cell growth factor-like polypeptides and polynucleotides'
[patent_app_type] => utility
[patent_app_number] => 11/985996
[patent_app_country] => US
[patent_app_date] => 2007-11-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 67162
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0241/20080241207.pdf
[firstpage_image] =>[orig_patent_app_number] => 11985996
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/985996 | Methods and materials relating to novel stem cell growth factor-like polypeptides and polynucleotides | Nov 18, 2007 | Abandoned |
Array
(
[id] => 4676842
[patent_doc_number] => 20080214473
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-09-04
[patent_title] => 'Small Peptides And Methods For Treatment Of Chronic Obstruction Pulmonary Disease'
[patent_app_type] => utility
[patent_app_number] => 11/942172
[patent_app_country] => US
[patent_app_date] => 2007-11-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 13112
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0214/20080214473.pdf
[firstpage_image] =>[orig_patent_app_number] => 11942172
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/942172 | Small Peptides And Methods For Treatment Of Chronic Obstruction Pulmonary Disease | Nov 18, 2007 | Abandoned |
Array
(
[id] => 4719360
[patent_doc_number] => 20080241882
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-10-02
[patent_title] => 'Methods and materials relating to novel stem cell growth factor-like polypeptides and polynucleotides'
[patent_app_type] => utility
[patent_app_number] => 11/985824
[patent_app_country] => US
[patent_app_date] => 2007-11-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 67163
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0241/20080241882.pdf
[firstpage_image] =>[orig_patent_app_number] => 11985824
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/985824 | Methods and materials relating to novel stem cell growth factor-like polypeptides and polynucleotides | Nov 15, 2007 | Abandoned |
Array
(
[id] => 5527240
[patent_doc_number] => 20090197317
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-08-06
[patent_title] => 'TSG-Like Gene'
[patent_app_type] => utility
[patent_app_number] => 11/940927
[patent_app_country] => US
[patent_app_date] => 2007-11-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 13255
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0197/20090197317.pdf
[firstpage_image] =>[orig_patent_app_number] => 11940927
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/940927 | TSG-Like Gene | Nov 14, 2007 | Abandoned |
Array
(
[id] => 4939396
[patent_doc_number] => 20080076715
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-03-27
[patent_title] => 'Methods and materials relating to stem cell growth factor-like polypeptides and polynucleotides'
[patent_app_type] => utility
[patent_app_number] => 11/983967
[patent_app_country] => US
[patent_app_date] => 2007-11-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 47608
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0076/20080076715.pdf
[firstpage_image] =>[orig_patent_app_number] => 11983967
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/983967 | Methods and materials relating to stem cell growth factor-like polypeptides and polynucleotides | Nov 12, 2007 | Abandoned |
Array
(
[id] => 83175
[patent_doc_number] => 07741057
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-06-22
[patent_title] => 'Method for screening for compounds using MHC class II invariant chain polypeptide and macrophage migration inhibitory factor'
[patent_app_type] => utility
[patent_app_number] => 11/931442
[patent_app_country] => US
[patent_app_date] => 2007-10-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 16
[patent_no_of_words] => 6966
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 143
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/741/07741057.pdf
[firstpage_image] =>[orig_patent_app_number] => 11931442
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/931442 | Method for screening for compounds using MHC class II invariant chain polypeptide and macrophage migration inhibitory factor | Oct 30, 2007 | Issued |
Array
(
[id] => 311200
[patent_doc_number] => 07528225
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-05-05
[patent_title] => 'Peptide epitopes of apolipoprotein B'
[patent_app_type] => utility
[patent_app_number] => 11/930625
[patent_app_country] => US
[patent_app_date] => 2007-10-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 11458
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/528/07528225.pdf
[firstpage_image] =>[orig_patent_app_number] => 11930625
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/930625 | Peptide epitopes of apolipoprotein B | Oct 30, 2007 | Issued |
Array
(
[id] => 5264493
[patent_doc_number] => 20090117178
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-05-07
[patent_title] => 'PEPTIDE EPITOPES OF APOLIPOPROTEIN B'
[patent_app_type] => utility
[patent_app_number] => 11/930910
[patent_app_country] => US
[patent_app_date] => 2007-10-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 11452
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0117/20090117178.pdf
[firstpage_image] =>[orig_patent_app_number] => 11930910
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/930910 | Peptide epitopes of apolipoprotein B | Oct 30, 2007 | Issued |
Array
(
[id] => 292071
[patent_doc_number] => 07544360
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-06-09
[patent_title] => 'Peptide epitopes of apolipoprotein B'
[patent_app_type] => utility
[patent_app_number] => 11/930859
[patent_app_country] => US
[patent_app_date] => 2007-10-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 11318
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/544/07544360.pdf
[firstpage_image] =>[orig_patent_app_number] => 11930859
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/930859 | Peptide epitopes of apolipoprotein B | Oct 30, 2007 | Issued |
Array
(
[id] => 5264452
[patent_doc_number] => 20090117137
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-05-07
[patent_title] => 'PEPTIDE EPITOPES OF APOLIPOPROTEIN B'
[patent_app_type] => utility
[patent_app_number] => 11/930969
[patent_app_country] => US
[patent_app_date] => 2007-10-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 11456
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0117/20090117137.pdf
[firstpage_image] =>[orig_patent_app_number] => 11930969
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/930969 | PEPTIDE EPITOPES OF APOLIPOPROTEIN B | Oct 30, 2007 | Abandoned |
Array
(
[id] => 4959745
[patent_doc_number] => 20080274170
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-11-06
[patent_title] => 'PEPTIDE EPITOPES OF APOLIPOPROTEIN B'
[patent_app_type] => utility
[patent_app_number] => 11/924010
[patent_app_country] => US
[patent_app_date] => 2007-10-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 11451
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0274/20080274170.pdf
[firstpage_image] =>[orig_patent_app_number] => 11924010
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/924010 | Peptide epitopes of apolipoprotein B | Oct 24, 2007 | Issued |
Array
(
[id] => 220863
[patent_doc_number] => 07608409
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-10-27
[patent_title] => 'Screening assay using G-protein coupled receptor protein OT7T175'
[patent_app_type] => utility
[patent_app_number] => 11/976414
[patent_app_country] => US
[patent_app_date] => 2007-10-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 32408
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 124
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/608/07608409.pdf
[firstpage_image] =>[orig_patent_app_number] => 11976414
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/976414 | Screening assay using G-protein coupled receptor protein OT7T175 | Oct 23, 2007 | Issued |
Array
(
[id] => 4903527
[patent_doc_number] => 20080112940
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-05-15
[patent_title] => 'Notch2 signaling as a breast cancer suppressor pathway'
[patent_app_type] => utility
[patent_app_number] => 11/975522
[patent_app_country] => US
[patent_app_date] => 2007-10-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 22536
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0112/20080112940.pdf
[firstpage_image] =>[orig_patent_app_number] => 11975522
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/975522 | Inhibiting breast cancer cell growth by administering an intracellular domain of NOTCH2 | Oct 18, 2007 | Issued |
Array
(
[id] => 4833361
[patent_doc_number] => 20080131908
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-06-05
[patent_title] => 'NOVEL ANTI-NOTCH3 ANTIBODIES AND THEIR USE IN THE DETECTION AND DIAGNOSIS OF DISEASE'
[patent_app_type] => utility
[patent_app_number] => 11/874645
[patent_app_country] => US
[patent_app_date] => 2007-10-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 16284
[patent_no_of_claims] => 42
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0131/20080131908.pdf
[firstpage_image] =>[orig_patent_app_number] => 11874645
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/874645 | Anti-Notch3 antibodies | Oct 17, 2007 | Issued |
Array
(
[id] => 6474882
[patent_doc_number] => 20100284933
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-11-11
[patent_title] => 'Biomarkers of Multiple Sclerosis'
[patent_app_type] => utility
[patent_app_number] => 12/445598
[patent_app_country] => US
[patent_app_date] => 2007-10-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 19507
[patent_no_of_claims] => 114
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0284/20100284933.pdf
[firstpage_image] =>[orig_patent_app_number] => 12445598
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/445598 | Biomarkers of Multiple Sclerosis | Oct 14, 2007 | Abandoned |
Array
(
[id] => 5952275
[patent_doc_number] => 20110033415
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-02-10
[patent_title] => 'AGENT FOR DIFFERENTIATING HEMATOPOIETIC STEM CELL INTO NATURAL KILLER CELL COMPRISING YC-1 OR IL-2 1 AND A METHOD OF DIFFERENTIATING HEMATOPOIETIC STEM CELL INTO NATURAL KILLER CELL USING THE SAME'
[patent_app_type] => utility
[patent_app_number] => 12/671814
[patent_app_country] => US
[patent_app_date] => 2007-10-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 4939
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0033/20110033415.pdf
[firstpage_image] =>[orig_patent_app_number] => 12671814
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/671814 | Method of differentiating hematopoietic stem cells into natural killer cells using YC-1 or IL-21 | Oct 1, 2007 | Issued |
Array
(
[id] => 6575993
[patent_doc_number] => 20100047207
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-02-25
[patent_title] => 'Therapeutic Composition To Improve The Effect Of The Therapy With Anti-Epidermal Growth Factor Receptor Antibodies'
[patent_app_type] => utility
[patent_app_number] => 12/442608
[patent_app_country] => US
[patent_app_date] => 2007-09-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 4342
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0047/20100047207.pdf
[firstpage_image] =>[orig_patent_app_number] => 12442608
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/442608 | Therapeutic Composition To Improve The Effect Of The Therapy With Anti-Epidermal Growth Factor Receptor Antibodies | Sep 26, 2007 | Abandoned |
Array
(
[id] => 6340087
[patent_doc_number] => 20100247551
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-09-30
[patent_title] => 'Use of Lipocalin 2 in the Regulation of Insulin Sensitivity'
[patent_app_type] => utility
[patent_app_number] => 12/438632
[patent_app_country] => US
[patent_app_date] => 2007-08-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 4313
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0247/20100247551.pdf
[firstpage_image] =>[orig_patent_app_number] => 12438632
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/438632 | Use of Lipocalin 2 in the Regulation of Insulin Sensitivity | Aug 28, 2007 | Abandoned |
Array
(
[id] => 8102933
[patent_doc_number] => 08153113
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-04-10
[patent_title] => 'Method of increasing trafficking of endothelial progenitor cells to ischemia-damaged tissue'
[patent_app_type] => utility
[patent_app_number] => 11/894581
[patent_app_country] => US
[patent_app_date] => 2007-08-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 50
[patent_figures_cnt] => 53
[patent_no_of_words] => 17505
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 73
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/153/08153113.pdf
[firstpage_image] =>[orig_patent_app_number] => 11894581
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/894581 | Method of increasing trafficking of endothelial progenitor cells to ischemia-damaged tissue | Aug 19, 2007 | Issued |
Array
(
[id] => 4771411
[patent_doc_number] => 20080057069
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-03-06
[patent_title] => 'Method of increasing trafficking of endothelial progenitor cells to ischemia-damaged tissue'
[patent_app_type] => utility
[patent_app_number] => 11/894555
[patent_app_country] => US
[patent_app_date] => 2007-08-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 51
[patent_figures_cnt] => 51
[patent_no_of_words] => 17402
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 20
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0057/20080057069.pdf
[firstpage_image] =>[orig_patent_app_number] => 11894555
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/894555 | Method of increasing trafficking of endothelial progenitor cells to ischemia-damaged tissue | Aug 19, 2007 | Abandoned |